News Conference News AHA 2023 Full SELECT Results Affirm CV Risk Reduction With Semaglutide in Nondiabetics Todd Neale November 11, 2023
News Conference News AHA 2023 RNA-Interference Agent Zilebesiran Looks Promising for BP: KARDIA-1 Caitlin E. Cox November 11, 2023
Presentation AHA 2023 Safety and Pharmacodynamic Effects of VERVE-101 Presenter: Andrew Bellinger November 11, 2023
Presentation AHA 2023 Lepodisiran: An Extended-Duration siRNA Targeting Lipoprotein(a) Presenter: Steven E. Nissen November 11, 2023
News Conference News AHA 2023 Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina Michael O'Riordan November 11, 2023
News Conference News AHA 2023 MINT Hints at Benefits of Liberal Transfusions in Acute MI With Anemia L.A. McKeown November 11, 2023
News Daily News FDA Grants Tirzepatide a New Indication for Obesity Management L.A. McKeown November 08, 2023
News Daily News FDA Approves Paradise Renal Denervation System: What Comes Next? Todd Neale November 08, 2023
News Conference News AHA 2023 Inflammation More Powerful Than LDL as CV Risk Predictor in Statin-Free Patients Caitlin E. Cox November 07, 2023
News Opinion Editor's Corner AHA 2023 What’s Going to Be Hot at AHA 2023 Shelley Wood November 07, 2023
News Conference News VIVA 2023 ‘Dire’ Lack of Vascular Care in Underserved Areas Needs Creativity, Compassion L.A. McKeown November 03, 2023
News Daily News Very High LDL Cholesterol Declines in US Adults, but Progress Is Slow Michael O'Riordan November 02, 2023
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2023 Shelley Wood November 01, 2023
News Conference News TCT 2023 RADIANCE: 'Modest' Renal Denervation Effect Remains at 6 Months Todd Neale October 31, 2023
News Daily News AHA Throws Its Support Behind New, Independent Medical Board Michael O'Riordan October 30, 2023
Presentation TCT 2023 TCT 535: Association between Sex and Clinical Presentation and Outcome in Acute Myocardial Infarction Related Cardiogenic Shock Presenter: Elma Peters October 26, 2023
Presentation TCT 2023 TCT 340: Sex Differences in Patients with Three-vessel Coronary Artery Disease Undergoing FFR-guided PCI or CABG: A Pre-specified Analysis of the FAME 3 Trial Presenter: Kuniaki Takahashi October 26, 2023